Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Journal: Nature Medicine

Published: 2020-06-05

DOI: 10.1038/s41591-020-0949-6

Affiliations: 18

Authors: 22

Go to article
Institutions Share
Nanfang Hospital, China 0.13
Guangzhou Kingmed Diagnostics Center Co. Ltd., China 0.09
State Key Laboratory of Organ Failure Research at Nanfang Hospital, SMU, China 0.09
National Clinical Research Center for Kidney Disease at Nanfang Hospital, SMU, China 0.09
MOE Key Laboratory of Molecular Biology for Infectious Diseases, CQMU, China 0.05
University of Electronic Science and Technology of China (UESTC), China 0.05
Sichuan Provincial People's Hospital, SAMSPH, China 0.05
Sichuan Provincial Key Laboratory for Human Disease Gene Study, SAMSPH, China 0.05
Department of Computer Science and Technology, Tsinghua, China 0.05
The Second People’s Hospital of Honghu, China 0.05
Department of Applied Biology and Chemical Technology (ABCT), PolyU, China 0.05
Honghu Traditional Chinese Medicine Hospital, China 0.05
Jingzhou Central Hospital, China 0.05
The First People’s Hospital of Jingzhou, China 0.05
The People's Hospital of Honghu, China 0.05
Foshan First People's Hospital, China 0.05
Guangzhou Institutes of Biomedicine and Health (GIBH), CAS, China 0.03
Faculty of Medicine, MUST, China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER